Trial intelligence / Profile preview

Olfactory neural responses as a measure of therapeutic success in functional anosmia

2011-002600-32Phase 2Completed

Sponsor
Klinische Abteilung für Neuroradiologie und Muskuloskeletale Radiologie, Medizinische Universität Wien
Start
Jul 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label trial of human insulin in anosmia (2 cohorts), sponsored by Klinische Abteilung für Neuroradiologie und Muskuloskeletale Radiologie, Medizinische Universität Wien. Started Jul 2011; status: completed.

02

Drugs

human insulin
03

Conditions

anosmia

Beyond the preview

Go deeper on 2011-002600-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002600-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call